 Mary Coussons-Read
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aggression | 6 | 2016 | 221 | 2.200 |
Why?
| | Interleukin-6 | 11 | 2019 | 706 | 1.680 |
Why?
| | C-Reactive Protein | 7 | 2016 | 349 | 1.480 |
Why?
| | Personality Disorders | 4 | 2019 | 75 | 1.250 |
Why?
| | Postpartum Period | 5 | 2021 | 259 | 1.170 |
Why?
| | Inflammation | 7 | 2021 | 2442 | 1.040 |
Why?
| | Pregnancy | 18 | 2022 | 5267 | 0.900 |
Why?
| | Depression, Postpartum | 2 | 2021 | 87 | 0.840 |
Why?
| | Sleep Initiation and Maintenance Disorders | 2 | 2021 | 134 | 0.820 |
Why?
| | Morphine | 6 | 2001 | 192 | 0.790 |
Why?
| | Kynurenine | 2 | 2019 | 69 | 0.780 |
Why?
| | Cytokines | 6 | 2015 | 1964 | 0.770 |
Why?
| | Stress, Psychological | 5 | 2012 | 1183 | 0.750 |
Why?
| | Biomarkers | 6 | 2021 | 3485 | 0.720 |
Why?
| | Depression | 4 | 2021 | 1186 | 0.690 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2012 | 1242 | 0.660 |
Why?
| | Pregnancy Trimesters | 2 | 2006 | 14 | 0.650 |
Why?
| | Anxiety | 3 | 2022 | 818 | 0.620 |
Why?
| | Pregnant Women | 2 | 2016 | 114 | 0.610 |
Why?
| | Receptors, Interleukin-1 Type II | 1 | 2015 | 6 | 0.580 |
Why?
| | Tryptophan | 1 | 2016 | 135 | 0.580 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 2 | 2016 | 14 | 0.570 |
Why?
| | Premature Birth | 2 | 2021 | 232 | 0.560 |
Why?
| | Pregnancy Complications | 4 | 2020 | 474 | 0.550 |
Why?
| | Health Status Indicators | 1 | 2013 | 178 | 0.480 |
Why?
| | Gestational Age | 4 | 2021 | 762 | 0.470 |
Why?
| | Adjuvants, Immunologic | 2 | 2008 | 230 | 0.460 |
Why?
| | Inflammation Mediators | 2 | 2013 | 545 | 0.460 |
Why?
| | Hydrocortisone | 3 | 2012 | 331 | 0.450 |
Why?
| | Sleep Deprivation | 2 | 2021 | 179 | 0.450 |
Why?
| | Adult | 24 | 2021 | 32077 | 0.430 |
Why?
| | Adaptation, Psychological | 2 | 2013 | 586 | 0.430 |
Why?
| | Social Support | 3 | 2016 | 552 | 0.410 |
Why?
| | Lymphocytes | 3 | 2008 | 387 | 0.390 |
Why?
| | Self Report | 1 | 2013 | 713 | 0.380 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2018 | 591 | 0.370 |
Why?
| | Animal Husbandry | 1 | 2009 | 22 | 0.370 |
Why?
| | Agricultural Workers' Diseases | 1 | 2009 | 35 | 0.360 |
Why?
| | Shiitake Mushrooms | 1 | 2008 | 1 | 0.350 |
Why?
| | Xylans | 1 | 2008 | 3 | 0.350 |
Why?
| | Orthomyxoviridae Infections | 2 | 1999 | 51 | 0.350 |
Why?
| | Oryza | 1 | 2008 | 20 | 0.350 |
Why?
| | Epigenesis, Genetic | 3 | 2021 | 488 | 0.350 |
Why?
| | Rats, Inbred Lew | 8 | 2008 | 108 | 0.350 |
Why?
| | Female | 28 | 2022 | 63070 | 0.350 |
Why?
| | Health Behavior | 1 | 2013 | 713 | 0.340 |
Why?
| | Sleep | 3 | 2021 | 731 | 0.340 |
Why?
| | Lymphocyte Activation | 6 | 2008 | 1101 | 0.330 |
Why?
| | Sleep Wake Disorders | 2 | 2008 | 308 | 0.320 |
Why?
| | Young Adult | 12 | 2021 | 10987 | 0.310 |
Why?
| | Seasons | 1 | 2009 | 438 | 0.310 |
Why?
| | Immunity, Cellular | 2 | 2001 | 303 | 0.310 |
Why?
| | Plant Extracts | 1 | 2008 | 173 | 0.300 |
Why?
| | Circadian Rhythm | 2 | 2012 | 439 | 0.300 |
Why?
| | Aging | 3 | 2021 | 1708 | 0.290 |
Why?
| | Impulsive Behavior | 3 | 2016 | 128 | 0.290 |
Why?
| | Spinal Puncture | 2 | 2015 | 27 | 0.280 |
Why?
| | Leukocytes, Mononuclear | 1 | 2007 | 489 | 0.280 |
Why?
| | Neuroimmunomodulation | 2 | 1995 | 111 | 0.270 |
Why?
| | Narcolepsy | 1 | 2004 | 25 | 0.270 |
Why?
| | Human Growth Hormone | 1 | 2004 | 49 | 0.270 |
Why?
| | Conditioning, Classical | 2 | 1995 | 113 | 0.270 |
Why?
| | Interferon-gamma | 3 | 2021 | 771 | 0.260 |
Why?
| | Killer Cells, Natural | 4 | 2008 | 331 | 0.260 |
Why?
| | Acculturation | 2 | 2016 | 54 | 0.260 |
Why?
| | Humans | 29 | 2022 | 114578 | 0.260 |
Why?
| | Mexican Americans | 2 | 2016 | 88 | 0.250 |
Why?
| | Catecholamines | 1 | 2002 | 121 | 0.240 |
Why?
| | Interleukin-2 | 3 | 2008 | 402 | 0.240 |
Why?
| | Chorioamnionitis | 1 | 2021 | 37 | 0.220 |
Why?
| | Personality Inventory | 2 | 2014 | 161 | 0.220 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2022 | 113 | 0.220 |
Why?
| | Male | 21 | 2020 | 60818 | 0.210 |
Why?
| | Picolinic Acids | 2 | 2019 | 3 | 0.210 |
Why?
| | Pregnancy Outcome | 3 | 2021 | 341 | 0.210 |
Why?
| | Receptors, Cannabinoid | 1 | 2019 | 15 | 0.200 |
Why?
| | Maternal Behavior | 1 | 2020 | 82 | 0.200 |
Why?
| | Interleukins | 1 | 2021 | 237 | 0.200 |
Why?
| | Longitudinal Studies | 4 | 2021 | 2666 | 0.190 |
Why?
| | Endocannabinoids | 1 | 2019 | 37 | 0.190 |
Why?
| | Birth Weight | 2 | 2020 | 410 | 0.190 |
Why?
| | Altitude | 1 | 2002 | 399 | 0.180 |
Why?
| | Prenatal Care | 1 | 2020 | 231 | 0.170 |
Why?
| | Personality | 1 | 2019 | 121 | 0.170 |
Why?
| | Rats | 8 | 2008 | 6201 | 0.170 |
Why?
| | Influenza A virus | 1 | 1999 | 109 | 0.170 |
Why?
| | Middle Aged | 9 | 2021 | 28854 | 0.170 |
Why?
| | Diabetes, Gestational | 1 | 2021 | 264 | 0.170 |
Why?
| | Orthomyxoviridae | 1 | 1998 | 35 | 0.170 |
Why?
| | Psychometrics | 2 | 2014 | 698 | 0.170 |
Why?
| | Quinolinic Acid | 1 | 2016 | 8 | 0.160 |
Why?
| | Kynurenic Acid | 1 | 2016 | 11 | 0.160 |
Why?
| | Placenta | 1 | 2022 | 584 | 0.160 |
Why?
| | Toxoplasmosis | 1 | 2016 | 28 | 0.150 |
Why?
| | Maze Learning | 1 | 1996 | 96 | 0.150 |
Why?
| | Adult Survivors of Child Abuse | 1 | 2015 | 20 | 0.150 |
Why?
| | Child Development | 1 | 2020 | 467 | 0.140 |
Why?
| | Exploratory Behavior | 1 | 1996 | 108 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 2 | 2022 | 81 | 0.140 |
Why?
| | Pregnancy Trimester, Third | 2 | 2022 | 77 | 0.140 |
Why?
| | Nadolol | 1 | 1994 | 8 | 0.140 |
Why?
| | Receptors, Opioid | 1 | 1994 | 37 | 0.140 |
Why?
| | Anti-Inflammatory Agents | 1 | 1999 | 461 | 0.140 |
Why?
| | Depressive Disorder | 1 | 2018 | 393 | 0.140 |
Why?
| | Receptors, Adrenergic, beta | 2 | 1994 | 157 | 0.140 |
Why?
| | Reference Values | 2 | 2008 | 852 | 0.130 |
Why?
| | Pilot Projects | 2 | 2020 | 1420 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2001 | 717 | 0.130 |
Why?
| | Interleukin-10 | 2 | 2006 | 318 | 0.130 |
Why?
| | Anxiety Disorders | 3 | 2022 | 306 | 0.130 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2015 | 268 | 0.130 |
Why?
| | Statistics as Topic | 1 | 2014 | 362 | 0.120 |
Why?
| | Lung | 3 | 2001 | 3558 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 1999 | 353 | 0.120 |
Why?
| | Antibody Formation | 1 | 1994 | 308 | 0.120 |
Why?
| | Mitogens | 2 | 2008 | 70 | 0.120 |
Why?
| | Models, Genetic | 1 | 1996 | 587 | 0.120 |
Why?
| | Serotonin | 1 | 2015 | 380 | 0.120 |
Why?
| | Dopamine | 1 | 2015 | 288 | 0.110 |
Why?
| | Nitric Oxide | 2 | 1994 | 897 | 0.110 |
Why?
| | Macrophages | 3 | 1998 | 1315 | 0.110 |
Why?
| | Down Syndrome | 1 | 1996 | 307 | 0.110 |
Why?
| | Saliva | 2 | 2012 | 216 | 0.110 |
Why?
| | Pituitary-Adrenal System | 2 | 2012 | 194 | 0.100 |
Why?
| | Suicidal Ideation | 1 | 2015 | 358 | 0.100 |
Why?
| | Motor Activity | 1 | 1996 | 751 | 0.100 |
Why?
| | Hypothalamo-Hypophyseal System | 2 | 2012 | 270 | 0.100 |
Why?
| | Immunosuppressive Agents | 1 | 1994 | 679 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2016 | 3249 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1994 | 0.100 |
Why?
| | Adolescent | 5 | 2016 | 18658 | 0.090 |
Why?
| | Lipopolysaccharides | 2 | 2007 | 955 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2015 | 1231 | 0.090 |
Why?
| | Suicide | 1 | 2016 | 570 | 0.090 |
Why?
| | Avena | 1 | 2008 | 3 | 0.090 |
Why?
| | Animals | 10 | 2008 | 34690 | 0.090 |
Why?
| | Superantigens | 1 | 2008 | 71 | 0.090 |
Why?
| | Enterotoxins | 1 | 2008 | 85 | 0.090 |
Why?
| | Cytotoxicity, Immunologic | 2 | 2001 | 212 | 0.090 |
Why?
| | Seeds | 1 | 2008 | 82 | 0.080 |
Why?
| | Bacterial Toxins | 1 | 2008 | 109 | 0.080 |
Why?
| | Pregnancy Trimester, First | 1 | 2007 | 121 | 0.080 |
Why?
| | Spleen | 2 | 2008 | 536 | 0.080 |
Why?
| | Life Change Events | 2 | 2021 | 136 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2007 | 4281 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 1996 | 3828 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 4408 | 0.070 |
Why?
| | Sleep Stages | 1 | 2004 | 82 | 0.070 |
Why?
| | Serum | 1 | 2004 | 66 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2008 | 455 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 942 | 0.060 |
Why?
| | Chronic Disease | 1 | 2009 | 1649 | 0.060 |
Why?
| | Fetal Death | 1 | 2021 | 53 | 0.060 |
Why?
| | Self Efficacy | 1 | 2005 | 353 | 0.060 |
Why?
| | Optimism | 1 | 2021 | 5 | 0.060 |
Why?
| | Nitrites | 1 | 2001 | 75 | 0.050 |
Why?
| | Nitrates | 1 | 2001 | 82 | 0.050 |
Why?
| | Injections, Subcutaneous | 1 | 2001 | 160 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 3280 | 0.050 |
Why?
| | Analysis of Variance | 1 | 2004 | 1496 | 0.050 |
Why?
| | Epigenomics | 1 | 2020 | 88 | 0.050 |
Why?
| | Glycerides | 1 | 2019 | 16 | 0.050 |
Why?
| | Arachidonic Acids | 1 | 2019 | 56 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2368 | 0.050 |
Why?
| | Estradiol | 1 | 2002 | 459 | 0.050 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2005 | 498 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1999 | 130 | 0.050 |
Why?
| | Colorado | 1 | 2009 | 4488 | 0.040 |
Why?
| | Sex Factors | 1 | 2004 | 1971 | 0.040 |
Why?
| | omega-N-Methylarginine | 2 | 1994 | 27 | 0.040 |
Why?
| | Concanavalin A | 2 | 1994 | 83 | 0.040 |
Why?
| | Drug Implants | 1 | 1998 | 81 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 5045 | 0.040 |
Why?
| | Mice, Neurologic Mutants | 1 | 1996 | 23 | 0.040 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 1996 | 30 | 0.040 |
Why?
| | DNA Methylation | 1 | 2020 | 415 | 0.040 |
Why?
| | Arginine | 2 | 1994 | 246 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1999 | 624 | 0.040 |
Why?
| | Anger | 1 | 2016 | 62 | 0.040 |
Why?
| | Deoxyguanosine | 1 | 2015 | 29 | 0.040 |
Why?
| | Mexico | 1 | 2016 | 151 | 0.040 |
Why?
| | Trisomy | 1 | 1996 | 60 | 0.040 |
Why?
| | Risk Factors | 3 | 2016 | 9078 | 0.040 |
Why?
| | Mice, Inbred C3H | 1 | 1996 | 271 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2007 | 4741 | 0.040 |
Why?
| | Arousal | 1 | 1996 | 204 | 0.030 |
Why?
| | Avoidance Learning | 1 | 1995 | 90 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 676 | 0.030 |
Why?
| | Naltrexone | 1 | 1994 | 90 | 0.030 |
Why?
| | Electroshock | 1 | 1994 | 270 | 0.030 |
Why?
| | Social Environment | 1 | 1996 | 360 | 0.030 |
Why?
| | Parent-Child Relations | 1 | 2015 | 234 | 0.030 |
Why?
| | Parenting | 1 | 2015 | 220 | 0.030 |
Why?
| | Proteins | 1 | 1999 | 952 | 0.030 |
Why?
| | Family | 1 | 2016 | 574 | 0.030 |
Why?
| | Body Mass Index | 1 | 2020 | 2052 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2016 | 795 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1196 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2012 | 128 | 0.030 |
Why?
| | Prospective Studies | 1 | 2021 | 6288 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 5000 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 1109 | 0.020 |
Why?
| | Mental Disorders | 1 | 2016 | 952 | 0.020 |
Why?
| | United States | 2 | 2016 | 12551 | 0.020 |
Why?
| | Infant | 1 | 2020 | 8097 | 0.020 |
Why?
| | Mothers | 1 | 2012 | 610 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 884 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4891 | 0.020 |
Why?
| | Mice | 1 | 1996 | 15432 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1994 | 348 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1229 | 0.010 |
Why?
|
|
Coussons-Read's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|